Albuquerque MV, Viana ALD, Lima LD, Ferreira MP, Fusaro ER, Iozzi FL (2017) Regional health inequalities: changes observed in Brazil from 2000–2016. Cien Saude Colet 22(4):1055–1064

Article  PubMed  Google Scholar 

American academy of pediatrics section on cardiology and cardiac surgery (2005) Cardiovascular health supervision for individuals affected by duchenne or becker muscular dystrophy. Pediatrics 116(6):1569–1573. https://doi.org/10.1542/peds.2005-2448

Aymé S, Kole A, Groft S (2008) Empowerment of patients: lessons from the rare diseases community. Lancet 371(9629):2048–2051

Article  PubMed  Google Scholar 

Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, Case LE, Cripe L, Hadjiyannakis S, Olson AK, Sheehan DW, Bolen J, Weber DR, Ward LM (2018) DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol 17(4):347–361

Article  PubMed  PubMed Central  Google Scholar 

Bobo JK, Kenneson A, Kolor K, Brown MA (2009) Adherence to American Academy of Pediatrics recommendations for cardiac care among female carriers of Duchenne And Becker muscular dystrophy. Pediatrics 123(3):e471–e475

Article  PubMed  Google Scholar 

Bogue L, Peay H, Martin A, Lucas A, Ramchandren S (2016) Knowledge of carrier status and barriers to testing among mothers of sons with Duchenne or Becker muscular dystrophy. Neuromuscul Disord 26(12):860–864

Article  PubMed  PubMed Central  Google Scholar 

Bonilla C, Albuquerque Sortica V, Schuler-Faccini L, Matijasevich A, Scheffer MC (2022) Medical geneticists, genetic diseases and services in Brazil in the age of personalized medicine. Per Med 19(6):549–563

Article  CAS  PubMed  Google Scholar 

Clemens PR, Rao VK, Connolly AM, Harper AD, Mah JK, Smith EC, McDonald CM, Zaidman CM, Morgenroth LP, Osaki H, Satou Y, Yamashita T, Hoffman EP (2020) CINRG DNHS Investigators. Safety, tolerability, and efficacy of viltolarsen in boys with Duchenne muscular dystrophy amenable to exon 53 skipping: a phase 2 randomized clinical trial. JAMA Neurol 77(8):982–991

Article  PubMed  Google Scholar 

Cohen SA, Bradbury A, Henderson V, Hoskins K, Bednar E, Arun BK (2019) Genetic counseling and testing in a community setting: quality, access, and efficiency. Am Soc Clin Oncol Educ Book 39:e34–e44

Article  PubMed  Google Scholar 

Davie AM, Emery AE (1978) Estimation of proportion of new mutants among cases of Duchenne muscular dystrophy. J Med Genet 15(5):339–345

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dragojlovic N, Borle K, Kopac N, Ellis U, Birch P, Adam S, Friedman JM, Nisselle A (2020) GenCOUNSEL Study; Elliott AM, Lynd LD The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review. Genet Med. 22(9):1437–1449

Eekhoff L, Edwards J, Martin A, Prijoles EJ (2019) Assessing the barriers to cardiac care in carriers of Duchenne and Becker muscular dystrophy. J Genet Couns 28(5):993–1002

Article  PubMed  Google Scholar 

Eggers S, Pavanello RC, Passos-Bueno MR, Zatz M (1999) Genetic counseling for childless women at risk for Duchenne muscular dystrophy. Am J Med Genet 86(5):447–453

Article  CAS  PubMed  Google Scholar 

Goldman A, Metcalfe A, MacLeod R (2018) The process of disclosure: mothers’ experiences of communicating X-linked carrier risk information to at-risk daughters. J Genet Couns 27(5):1265–1274

Article  PubMed  PubMed Central  Google Scholar 

Government Accountability Office (GAO) (2020) https://www.gao.gov/assets/gao-20-593.pdf

Grant PE, Pampaka M, Payne K, Clarke A, McAllister M (2019) Developing a short-form of the Genetic Counselling Outcome Scale: The Genomics Outcome Scale. Eur J Med Genet 62(5):324–334

Article  PubMed  Google Scholar 

Hayes B, Hassed S, Chaloner JL, Aston CE, Guy C (2016) Duchenne muscular dystrophy: a survey of perspectives on carrier testing and communication within the family. J Genet Couns 25(3):443–453

Article  PubMed  Google Scholar 

Horovitz DD, de Faria Ferraz VE, Dain S, Marques-de-Faria AP (2013) Genetic services and testing in Brazil. J Community Genet. 4(3):355–375. https://doi.org/10.1007/s12687-012-0096-y

Huyard C (2009) Who rules rare disease associations? A framework to understand their action. Sociol Health Illn 31(7):979–993

Article  PubMed  Google Scholar 

Jenkins BD, Fischer CG, Polito CA, Maiese DR, Keehn AS, Lyon M, Edick MJ, Taylor MRG, Andersson HC, Bodurtha JN, Blitzer MG, Muenke M, Watson MS (2021) The 2019 US medical genetics workforce: a focus on clinical genetics. Genet Med 23(8):1458–1464

Article  PubMed  PubMed Central  Google Scholar 

Kobayashi M, Hatakeyama T, Ishizaki M, Adachi K, Morita M, Yonemoto N, Matsumura T, Toyoshima I, Kimura E (2018) Medical attitudes survey for female dystrophinopathy carriers in Japan. Intern Med 57(16):2325–2332

Article  PubMed  PubMed Central  Google Scholar 

Maiese DR, Keehn A, Lyon M, Flannery D, Watson M (2019) Working groups of the national coordinating center for seven regional genetics service collaboratives. Current conditions in medical genetics practice. Genet Med 21(8):1874–1877

Article  PubMed  PubMed Central  Google Scholar 

Marmot M (2005) Social determinants of health inequalities. Lancet 365(9464):1099–1104

Article  PubMed  Google Scholar 

Mavrogeni SI, Markousis-Mavrogenis G, Papavasiliou A, Papadopoulos G, Kolovou G (2018) Cardiac involvement in Duchenne muscular dystrophy and related dystrophinopathies. Methods Mol Biol 1687:31–42

Article  CAS  PubMed  Google Scholar 

McAllister M, Wood AM, Dunn G, Shiloh S, Todd C (2011) The Genetic Counseling Outcome Scale: a new patient-reported outcome measure for clinical genetics services. Clin Genet 79(5):413–424

Article  CAS  PubMed  Google Scholar 

McDonald CM, Campbell C, Torricelli RE, Finkel RS, Flanigan KM, Goemans N, Heydemann P, Kaminska A, Kirschner J, Muntoni F, Osorio AN, Schara U, Sejersen T, Shieh PB, Sweeney HL, Topaloglu H, Tulinius M, Vilchez JJ, Voit T, Wong B, Elfring G, Kroger H, Luo X, McIntosh J, Ong T, Riebling P, Souza M, Spiegel RJ, Peltz SW, Mercuri E (2017) Clinical Evaluator Training Group; ACT DMD Study Group. Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 390(10101):1489–1498

Article  CAS  PubMed  Google Scholar 

McDonald CM, Shieh PB, Abdel-Hamid HZ, Connolly AM, Ciafaloni E, Wagner KR, Goemans N, Mercuri E, Khan N, Koenig E, Malhotra J, Zhang W, Han B, Mendell JR (2021) The Italian DMD Telethon Registry Study Group, Leuven NMRC Registry Investigators, CINRG Duchenne Natural History Investigators, and PROMOVI Trial Clinical Investigators. Open-label evaluation of eteplirsen in patients with Duchenne muscular dystrophy amenable to Exon 51 skipping: PROMOVI trial. J Neuromuscul Dis 8(6):989–1001

Article  PubMed  PubMed Central  Google Scholar 

Mendell JR, Sahenk Z, Lehman K, Nease C, Lowes LP, Miller NF, Iammarino MA, Alfano LN, Nicholl A, Al-Zaidy S, Lewis S, Church K, Shell R, Cripe LH, Potter RA, Griffin DA, Pozsgai E, Dugar A, Hogan M, Rodino-Klapac LR (2020) Assessment of systemic delivery of rAAVrh74.MHCK7. micro-dystrophin in children with Duchenne muscular dystrophy: a nonrandomized controlled trial. JAMA Neurol 77(9):1122–1131

Article  PubMed  Google Scholar 

Mercuri E, Bönnemann CG, Muntoni F (2019) Muscular dystrophies. Lancet 394(10213):2025–2038

Article  PubMed  Google Scholar 

Mitelman O, Abdel-Hamid HZ, Byrne BJ, Connolly AM, Heydemann P, Proud C, Shieh PB, Wagner KR, Dugar A, Santra S, Signorovitch J, Goemans N; investigators from the LNMRC Natural History study, McDonald CM (2022) investigators from the CINRG Duchenne National History Study, Mercuri E; investigators from The DMD Italian Group, Mendell JR. A combined prospective and retrospective comparison of long-term functional outcomes suggests delayed loss of ambulation and pulmonary decline with long-term eteplirsen treatment. J Neuromuscul Dis 9(1):39–52

Ministério da Educação (MEC) (2018) http://portal.mec.gov.br/index.php?option=com_docman&view=download&alias=102841-matriz-genetica-medica&category_slug=novembro-2018-pdf&Itemid=30192

Nadkarni JJ, Dastur RS, Viswanathan V, Gaitonde PS, Khadilkar SV (2008) Duchenne and Becker muscular dystrophies: an Indian update on genetics and rehabilitation. Neurol India 56(3):248–253

Article  PubMed  Google Scholar 

Segundo-Ribeiro M, Bacalá BT, Alvarenga WA, Nascimento LC, McAllister M, Flória-Santos M (2020) Adaptation and preliminary validation of the genetic counseling outcome scale (GCOS-24) in a Brazilian genetic counseling setting. Eur J Med Genet 63(11):104018

Article  PubMed  Google Scholar 

Soltanzadeh P, Friez MJ, Dunn D, von Niederhausern A, Gurvich OL, Swoboda KJ, Sampson JB, Pestronk A, Connolly AM, Florence JM, Finkel RS, Bönnemann CG, Medne L, Mendell JR, Mathews KD, Wong BL, Sussman MD, Zonana J, Kovak K, Gospe SM Jr, Gappmaier E, Taylor LE, Howard MT, Weiss RB, Flanigan KM (2010) Clinical and genetic characterization of manifesting carriers of DMD mutations. Neuromuscul Disord 20(8):499–504

Article  PubMed  PubMed Central  Google Scholar 

Ting MSO, Clarke A, McAllister M (2021) Assessing sensitivity to change of the genomics outcome scale (GOS). J Genet Couns 30(6):1767–1772

Article  PubMed  Google Scholar 

Viggiano E, Ergoli M, Picillo E, Politano L (2016) Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy. Hum Genet 135(7):685–698

Article  CAS  PubMed  Google Scholar 

Zatz M (1983) Effects of genetic counseling on Duchenne muscular dystrophy families in Brazil. Am J Med Genet 15(3):483–490

Article  CAS  PubMed  Google Scholar